A homogeneous cell-based assay to measure nuclear translocation using β-galactosidase enzyme fragment complementation

Assay and Drug Development Technologies

Volumn 4, Issue 3, 2006, Pages 263-272

  Fung, P ^a   Peng, K ^a   Kobel, P ^a   Dotimas, H ^a   Kauffman, L ^a   Olson, K ^a   Eglen, R M ^a  

^a DiscoveRx Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CELL PROTEIN; GLUCOCORTICOID RECEPTOR; HYBRID PROTEIN;

ALPHA CHAIN; ARTICLE; AUTOMATION; BINDING AFFINITY; BIOASSAY; CELL NUCLEUS; CHO CELL; COMPLEX FORMATION; CYTOLYSIS; HIGH THROUGHPUT SCREENING; IMAGING; INSTRUMENTATION; INTRACELLULAR SPACE; MICROTITER PLATE ASSAY; MOLECULAR INTERACTION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REPORTER GENE; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BETA-GALACTOSIDASE; BIOLOGICAL ASSAY; CHO CELLS; CRICETINAE; CRICETULUS; MICROSCOPY, FLUORESCENCE; PEPTIDE FRAGMENTS; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS;

EID: 33746104952     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2006.4.263     Document Type: Article

References (28)

1. O'Rourke NA, Meyer T, Chandy G: Protein localization studies in the age of 'Omics.' Curr Opin Chem Biol 2005;9:82-87.
2. Wouter FS, Verveer PJ, Bastiaens PIH: Imaging chemistry inside cells. Trends Cell Biol 2001;11:203-211.
3. Abraham VC, Vivek C, Taylor DL: High content screening applied to large scale cell biology. Trends Biotechnol 2004;22:15-22.
4. Comley J: High content screening: emerging importance of novel reagents/ probes and pathway analysis. Drug Discov World 2005;(Summer):31-53.
5. Entzeroth M: Emerging trends in high-throughput screening. Curr Opin Pharmacol 2003;3:522-529.
6. Giuliano KA, Haskins JR, Taylor DL: Advances in high content screening for drug discovery. Assay Drug Dev Technol 2003;1:565-577.
7. Moore K, Rees S: Cell-based versus isolated target screening: how lucky do you feel? J Biomol Screen 2001;6:69-74.
8. Ullmann A, Jacob F, Monod J: Characterization by in vitro complementation of a peptide corresponding to an operator-proximal segment of the β-galactosidase structural gene of Escherichia coli. J Mol Biol 1967;24: 339-343.
9. Zhao X, Vainshtein I, Gellibolian R, Shu Y, Dotimas H, Mei X, Fung P, Horecka J, Bosano B, Eglen RM: Homogeneous assays for cellular protein degradation using β-galactosidase complementation: NF-κB /IκB pathway signaling. Assay Drug Dev Technol 2003;1:823-833.
10. Mooseman O, Rusconi S: Alpha complementation of Lac Z in mammalian cells. Nucleic Acids Res 1996;24:1171-1172.
11. Khanna PL, Coty WA: Cloned enzyme donor immunoassay. In: Methods of Immunological Analysis, Vol. 1 (Masseyeff RF, Albert WH, Staines NA, eds.), p. 416. Weinheim, Germany: VCH Verlagsgesellschaft, 1993.
12. Homma T, Yoshihisa T, Kihara A, Akiyama Y, Ito K: Intracellular stability of a fragments of β galactosidase: effects of amino-terminally fused polypeptides. Biochem Biophys Res Commun 1995;215:452-458.
13. Rossi F, Charlton CA, Blau HM: Monitoring protein-protein interactions in intact eukaryotic cells by β galactosidase complementation. Proc Natl Acad Sci U S A 1997;94: 8405-8410.
14. Laurence HL, Bradley JS, Phelan ML, Kalnine NN, Nguyen YH, Kabakova T, Chen X, Tan M, Chang C, Berlon C, Gonzalez RC, Gao G-J, Golz S, Vysotski ES, Farmer AA: Large scale, highthroughput validation of short hairpin RNA sequences for RNA interference. J Biomol Screen 2006;11:236-246.
15. Wehrman TS, Casipit CL, Gewertz NM, Blau HM: Enzymatic detection of protein translocation. Nat Methods 2005; 2:521-527.
16. Hager GL, Lim CS, Elbi C, Baumann CT: Trafficking of nuclear receptors in living cells. J Steroid Biochem Mol Biol 2000;74:249-254.
17. Hayashi R, Wada H, Ito K, Adcock IM: Effects of glucocorticoids on gene transcription. Eur J Pharmacol 2004; 500:51-62.
18. Htun H, Barsonyt J, Renyit I, Gouldt DI, Hager G: Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. Proc Natl Acad Sci U S A 1999; 93:4845-4850.
19. Takahashi Y, Sawada R, Ishibashi K, Mikuni S, Kinjo M: Analysis of cellular functions by multipoint fluorescence correlation spectroscopy. Curr Pharm Biotechnol 2005;6: 159-165.
20. Saphire ACS, Black SJ, Gerace L: All four homochiral enantiomers of a nuclear localization sequence derived from c-myc serve as functional import signals. J Biol Chem 1998;273:29764-29769.
21. Horecka J, Charter NW, Bosano B, Fung, P, Peng K, Eglen RM: A novel antibody-free method for protein blotting using enzyme fragment complementation. Biotechniques 2006;40:381-383.
22. Kurien BT, Scofield RH: Protein blotting: a review. J Immunol Methods 2002;274:1-15.
23. Zhang J-H, Chung T, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.
24. Galigniana MD, Scruggs JL, Herrington J, Welsh MJ, Carter-Su C, Housley PR, Pratt WB: Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton. Mol Endocrinol 1998; 12:1903-1913.
25. Eglen RM: Enzyme fragment complementation: a flexible high throughput screening assay technology. Assay Drug Dev Technol 2002;1:97-104.
26. Eglen RM, Singh R: β Galactosidase enzyme fragment complementation as a novel technology for high throughput screening. Comb Chem High Throughput Screen 2003; 6:381-387.
27. Weber M, Ferrer M, Zheng W, Inglese J, Strulovici B, Kunapuli P: A 1536 well cAMP assay for Gs- and Gi-coupled receptors using enzyme fragment complementation. Assay Drug Dev Technol 2004;2:39-49.
28. Golla R, Seethala R: A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists. J Biomol Screen 2002;7:515-525.